25 results
8-K
EX-99.3
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
or withdraw their approvals of TNT119;
Tenet may be obliged to conduct a product recall or product withdrawal;
regulatory authorities may require additional
DEFM14A
ELYM
Eliem Therapeutics Inc
4 Jun 24
Proxy related to merger
8:00am
;
regulatory authorities may suspend, vary or withdraw their approvals of TNT119;
Tenet may be obliged to conduct a product recall or product withdrawal
PREM14A
ELYM
Eliem Therapeutics Inc
17 May 24
Preliminary proxy related to merger
4:36pm
to conduct a product recall or product withdrawal;
regulatory authorities may require additional warnings on the label that could diminish the usage
DEFA14A
ELYM
Eliem Therapeutics Inc
11 Apr 24
Additional proxy soliciting materials
8:10am
, suspension or recall), in each case alleging that the Company is not currently in compliance with any and all applicable Laws implemented by the FDA … manuals, frequently asked questions, release notes, recall notices, error logs, diagnostic reports, marketing materials, packaging, labeling, service
8-K
EX-2.1
2ra2t 9fm
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
8-K
EX-10.4
jwwge8gi3 628
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
10-K
rlxkucbh
7 Mar 22
Annual report
4:03pm
10-Q
v309ady5e 1a4skx
13 Sep 21
Quarterly report
4:01pm
424B4
7gzc796io5thu5kcjskd
11 Aug 21
Prospectus supplement with pricing info
5:05pm